Sign in

You're signed outSign in or to get full access.

John Allison

John Allison

Chief Executive Officer at HOME BANCSHARESHOME BANCSHARES
CEO
Executive
Board

About John W. Allison

John W. Allison (age 78) is co‑founder, Executive Chairman, Chairman of the Board, and since 2019 also Chief Executive Officer of Home BancShares (HOMB). He has served on the board since 1998 and has 40+ years of banking experience, including prior roles as Chairman of First National Bank of Conway and director at First Commercial Corporation before founding HOMB . Under his leadership, HOMB delivered record 2024 results: total revenue of $1.02B, net income of $402.2M, and EPS of $2.01, with five‑year cumulative TSR value of $166.26 on $100 invested vs $143.68 for the peer index; he is the largest individual shareholder with 7,110,425 shares (3.58%) .

Board governance: Allison combines CEO and Chair roles; the Board maintains an independent Vice Chairman (leads executive sessions) and reports 80% independent directors. Allison serves on the Asset/Liability Committee; he is not independent (employee) and is the brother‑in‑law of director/executive Donna Townsell, a governance consideration for independence/perceived influence .

Past Roles

OrganizationRoleYearsStrategic impact
Home BancShares, Inc.Executive Chairman (co‑founder)1998–presentGuided growth strategy; 25 bank/portfolio acquisitions; extended period of record earnings
Home BancShares, Inc.Chief Executive Officer1998–2009; 2019–presentReassumed CEO role in 2019 to drive performance and succession planning
First National Bank of ConwayChairman1983–1998Led largest AR bank holding company affiliate before sale of parent (First Commercial)
First Commercial CorporationDirector; Committee Chair roles1985–1998Experience overseeing executive and asset quality committees at public bank holding company

External Roles

OrganizationRoleYearsNotes
Capital Buyers (private company)OwnerNot disclosedEntity referenced in perquisites (aircraft ownership/utilization)

Fixed Compensation

Component202320242025Notes
Base salary$750,000 $750,000 $800,000 2024 reinstatement following late‑2023 temporary reduction; 2025 +6.7%
Director/committee fees (Company + bank/regional)$179,125 Paid in addition to executive role
Other 2024 perquisites/“All other compensation” detail401(k): $9,900; Auto allowance: $21,667; Country club dues: $8,835; Company‑owned life insurance ownership: $15,382; Board fees: $65,250; Bank/regional boards: $13,000; Committee fees: $100,875; Personal use of company pilots on privately owned aircraft: $7,500; Income from 2007 Chairman’s retirement plan: $250,000; Restricted stock dividends: $342,000 Company owns one aircraft (purchased from Capital Buyers in 2017) and at times uses another owned by Capital Buyers; reimbursement policies apply

Performance Compensation

2024 Annual Cash Incentive (Executive Incentive Plan)

MetricWeight (CEO)TargetActualPayout mechanics
Return on Avg Assets (as adjusted)20%≥ 1.20%1.77%Absolute measure; met
Return on Tangible Common Equity (as adjusted)20%≥ 10%16.64%Absolute; met
Efficiency ratio (as adjusted)20%< 47%42.65%Absolute; met
Net charge‑off ratio20%≤ 1%0.10%Absolute; met
Individual performance20%Committee discretionPaid within plan rules
Peer ROAA≥ 66 2/3rd percentile93.67%Relative; for other NEOs; CEO plan emphasizes absolutes
Peer ROTCE≥ 66 2/3rd percentile87.33%Relative; other NEOs
Peer Efficiency≥ 66 2/3rd percentile92.67%Relative; other NEOs
Peer Net Interest Margin≥ 66 2/3rd percentile94.33%Relative; other NEOs
  • 2024 CEO EIP bonus earned/paid: $750,000 (100% of base salary) .
  • Clawback: applies in case of restatements or if peer comparisons used without full‑year data later fall short; also subject to NYSE/SEC clawback policy .

Performance‑based Equity and Time‑based Equity

GrantTypeSizeMetric weights and goalsStatus/Vesting
Jan 19, 2024 CEO grantPerformance‑based RSUp to 100,000 shsNet Interest Margin, ROTCE, Efficiency, ROAA – each 25%; vesting at 50%/75%/100% for peer group percentile ranks at 25th/50th/66 2/3rd; performance period 3 yrsVests after 12/31/2026 upon committee certification; clawback applies
Jan 19, 2024 CEO grantTime‑based RS50,000 shsCliff vest Jan 19, 2027
Jan 19, 2024 Director grantTime‑based RS3,000 shs3 equal annual installments beginning Jan 19, 2025
Jan 2022 CEO grantPerformance‑based RS100,000 shsSame performance suite; 3‑yr period ended 12/31/2024Vested at 100% (≥87th percentile) in Jan 2025 upon certification
  • Plan‑level clawback provisions also allow recoupment for policy breaches or restatements; NYSE/SEC compliant policy adopted Oct 2023 .

Equity Ownership & Alignment

ItemAmountNotes
Beneficial ownership7,110,425 shs (3.58% of outstanding)Includes spouse/IRA/401(k) and 456,000 restricted shares; remains largest individual shareholder
Unvested RS (time‑based)156,000 shsSum of time‑based awards outstanding as of 12/31/2024
Unvested RS (performance‑based, “unearned”)300,000 shsThree 100,000‑share tranches tied to 3‑yr periods (2022–2024, 2023–2025, 2024–2026); the 2022 tranche vested 1/18/2025
Stock optionsNone outstandingNo options listed for Allison
Shares pledgedNone disclosed for AllisonPledging disclosed for certain other insiders; not for Allison
Hedging/derivatives policyProhibits directors/officers from trading Company put/call options; insider trading policy in placeAlignment‑supportive

Forthcoming vesting and potential selling pressure windows

Date/EventSharesDetail
Jan 18–21, 2025100,000 (perf) + 51,000 + 1,000 + 1,0002022 perf tranche vested (100k) 1/18/2025; time‑based 50k and 1k tranches vested 1/21/2025; 1k installment from a 2,000‑share grant and first 1,000 of 3,000 director RS on 1/20/2025
Jan 20, 20261,000 + 50,000Second 1,000 of 2,000‑share grant; separate 50,000 cliff vest
After 12/31/2025Up to 100,000 (perf)2023–2025 performance‑based tranche, subject to committee certification
Jan 19–20, 20271,000 + 50,000Final 1,000 director RS installment; 50,000 cliff vest
After 12/31/2026Up to 100,000 (perf)2024–2026 performance‑based tranche, subject to committee certification

Note: EIP cash awards are paid in January following the performance year (no CEO deferral); other NEOs have partial 3‑year deferrals .

Employment Terms

  • Chairman’s Agreement (effective Mar 1, 2021; term through Dec 31, 2030): base salary $500,000 (or higher per Committee); annual cash bonus opportunity up to 100% of base; annual RS awards up to 150,000 shares with 2/3 performance‑based and 1/3 time‑based; full employee benefits and perquisites .
  • Chairman Emeritus transition (if invoked): salary reduces to $400,000; no new equity or annual bonus; prior awards continue vesting; still employed, benefits continue .
  • Termination/death/disability economics for Allison (as of 12/31/2024):
    • Death: accelerated RS value $10.07M; cash $2.80M (includes 2x Chairman Emeritus salary, $750k earned bonus, $1.25M life insurance); total $12.88M .
    • Disability: accelerated RS value $10.07M; cash $1.55M; total $11.62M .
    • Change‑in‑control: RS accelerate ($10.07M) subject to performance conditions for performance‑based tranches; no additional cash for Allison .
  • Equity acceleration terms: Time‑based awards accelerate at change‑in‑control; performance‑based vest to extent goals met as of change‑in‑control date; as of Feb 7, 2025, death/disability triggers full vesting of all Allison equity (amended) .
  • Clawbacks: Plan‑level and Chairman’s Agreement clawbacks tied to financial restatements, peer‑metric remeasurement, or misconduct; NYSE/SEC compliant policy adopted Oct 2023 .
  • Say‑on‑Pay support: 93.1% approval at 2024 annual meeting .
  • Compensation governance: Independent Compensation & Leadership Development Committee; did not engage an external compensation consultant in 2024; peers used primarily for performance benchmarking (10–50B assets) .

Board Governance (Director Service, Committees, Independence)

  • Board service history: Director since 1998; serves as Chairman and CEO .
  • Committee roles: Asset/Liability Committee member .
  • Independence: Not independent (employee). Board independence: 80% independent; committees (Audit, Compensation, Nominating) fully independent .
  • Dual‑role implications: Combined CEO/Chair role offset by independent Vice Chairman who leads executive sessions and acts as liaison between independent directors and management .
  • Attendance: The Board held 4 regular and 2 special meetings in 2024; all directors met ≥75% attendance; all attended the 2024 Annual Meeting .

Compensation Structure Analysis

  • Mix and alignment: Majority of CEO pay is equity‑based; two‑thirds of annual equity is performance‑based vs peers over 3 years; annual cash bonus formulaic with absolute and relative financial metrics; substantial clawbacks across programs .
  • Metric stringency: In 2024, the Committee increased EIP peer target rigor (relative measures) but reduced the maximum percentile hurdle for CEO performance RS from 75th to 66 2/3rd to align with the revised EIP peer targets—potentially easing the maximum equity payout threshold vs prior years .
  • Consultant usage: None in 2024; peer data used informally (no target percentile for total comp) .
  • Pay vs performance: “Compensation Actually Paid” to CEO tracks TSR and financial metrics; 2024 TSR vs peers (HOMB 166.26 vs peers 143.68) and ROAA 1.77% underscore alignment .

Multi‑year compensation (CEO)

YearSalaryStock awards (grant‑date fair value)Non‑equity incentive (EIP)All other compTotal
2022$650,600 $3,661,290 $650,000 $687,747 $5,747,086
2023$707,351 $3,431,790 $750,000 $814,931 $5,788,859
2024$745,512 $3,765,330 $750,000 $834,409 $6,166,326

Related‑Party and Risk Indicators

  • Section 16(a) compliance: Two Form 4 reports for Allison were not filed timely in 2024 (administrative timeliness issue) .
  • Related‑party usage: Company owns an aircraft originally purchased in 2017 from Allison’s company (Capital Buyers); company also occasionally uses Capital Buyers’ aircraft and reimburses expenses; Allison’s personal use of company‑employed pilots was imputed at $7,500 in 2024 .
  • Family relationship: Allison is brother‑in‑law of director/executive Donna Townsell (SVP/IR), a governance sensitivity for independence .
  • Pledging/hedging: No pledging disclosed for Allison; policy discourages derivative trading by insiders .

Equity Award and Vesting Detail (selected)

AwardShares outstanding (12/31/24)Vesting terms
Time‑based RS (various)1,000; 2,000; 50,000; 50,000; 50,000; 3,0001,000/2,000 installments vest Jan 2025/Jan 2026; 50,000 vests Jan 2026; 50,000 vests Jan 2027; 50,000 vested Jan 21, 2025; 3,000 vests Jan 2025/2026/2027
Performance RS (2022 tranche)100,000Vested at 100% on Jan 18, 2025 (3‑yr period ended 12/31/2024)
Performance RS (2023 tranche)100,0003‑yr period ending 12/31/2025; vest post‑certification
Performance RS (2024 tranche)100,0003‑yr period ending 12/31/2026; vest post‑certification

Employment Contracts, Severance and CoC

ProvisionTerms
ContractChairman’s Agreement through 12/31/2030; CEO duties do not alter Chairman compensation .
Bonus targetUp to 100% of base salary (EIP) .
EquityUp to 150,000 RS annually (2/3 performance‑based) .
Chairman Emeritus$400,000 salary; no bonus/new equity; awards continue vesting .
Death/DisabilityLump sum = 2x Chairman Emeritus salary; spouse insurance coverage; as of Feb 2025, all unvested equity fully vests upon death/disability .
Change‑in‑controlTime‑based RS accelerate; performance RS vest only to extent goals met; no additional cash for Allison .

Investment Implications

  • Alignment and retention: Allison’s substantial ownership (3.58%) and heavy equity mix (with multi‑year performance RS) create strong alignment; multi‑year vesting plus Chairman’s Agreement through 2030 reduce near‑term retention risk .
  • Watch vesting windows: Large January vesting and certification events (notably in 2026 and 2027) could create episodic Form 4 activity and sell‑to‑cover dynamics; monitor filings around mid‑January each year and after year‑end performance certification .
  • Governance checks: Combined CEO/Chair role is partially mitigated by an independent Vice Chair and independent committees, but the family relationship with a director/executive and occasional related‑party aircraft usage warrant continued oversight; Section 16 timeliness lapses, while minor, are worth monitoring for process discipline .
  • Metric calibration: Lowering the maximum equity performance hurdle from 75th to 66 2/3rd percentile in 2024 makes top‑end vesting incrementally more attainable; offset by higher peer targets in cash EIP—investors should track realized performance vs. peers to assess true rigor and pay‑for‑performance .
  • Change‑in‑control exposure: Allison has no cash CIC parachute; equity acceleration is largely standard for time‑based and performance‑conditioned for performance RS—keeps CoC costs contained for the CEO .